Pfizer | featured news

Pfizer bid for Wyeth could top $65 billion: WSJ

Pfizer bid for Wyeth could top $65 billion: WSJ

Pfizer Inc. reportedly is close to an agreement to acquire rival drug maker Wyeth for between $65 billion and $70 billion in a cash-and-stock deal that could be announced as early as next week,

 

Subscribe to this RSS topic: Syndicate content